Company profile: Lobe Sciences
1.1 - Company Overview
Company description
- Provider of life sciences focused on transformational medicine.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Lobe Sciences
Levicept
HQ: United Kingdom
Website
- Description: Provider of biological therapies for chronic pain, including LEVI-04 (p75NTR-Fc) for knee osteoarthritis that modulates the neurotrophin pathway to minimize side effects associated with anti-NGF antibodies, and a Phase II randomized, double-blind, placebo-controlled clinical trial assessing its efficacy, safety, and tolerability.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Levicept company profile →
Synosia Therapeutics
HQ: Switzerland
Website
- Description: Provider of therapies for unmet medical needs in psychiatry and neurology. The privately-owned company develops and intends to commercialise products, with a pipeline of six clinical-stage compounds acquired through partnerships with Novartis, Roche and Syngenta. Two of the compounds are marketed drugs being tested in new indications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synosia Therapeutics company profile →
Annovis Bio
HQ: United States
Website
- Description: Provider of treatments for Alzheimer’s, Parkinson’s, and other neurodegenerative disorders, including: Buntanetap, an oral small molecule inhibiting multiple neurotoxic proteins; ANVS405, an IV formulation for acute neurodegeneration like TBI and stroke; and ANVS301, a Phase 1 compound aiming to increase cognitive capabilities in later-stage Alzheimer’s and dementia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Annovis Bio company profile →
Noema Pharma
HQ: Switzerland
Website
- Description: Provider of biotech therapies addressing disabling symptoms in orphan conditions of the brain and nervous system, with a pipeline including Phase 2b trials for childhood-onset fluency disorder (stuttering), tuberous sclerosis complex (seizures) and trigeminal neuralgia (severe pain), a Phase 2a trial in Tourette syndrome (involuntary tics), and a Phase 2-ready triple reuptake inhibitor for atypical depression and binge eating disorder.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Noema Pharma company profile →
Noctrix Health
HQ: United States
Website
- Description: Provider of early-stage medical device development, focusing on creating a revolutionary therapy for a chronic illness.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Noctrix Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Lobe Sciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Lobe Sciences
2.2 - Growth funds investing in similar companies to Lobe Sciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Lobe Sciences
4.2 - Public trading comparable groups for Lobe Sciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →